Stenger Family Office’s AbbVie ABBV Stock Holding History

Stenger Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.43M	Buy	33,496 +2,005	+6%	+$431K	1.34%	20
2026 Q1	$6.85M	Buy	31,491 +4,351	+16%	+$965K	1.21%	22
2025 Q4	$6.2M	Buy	27,140 +10,535	+63%	+$2.4M	1.28%	21
2025 Q3	$3.79M	Buy	16,605 +1,818	+12%	+$370K	0.78%	37
2025 Q2	$2.8M	Buy	+14,787	New	+$2.75M	0.72%	35
2024 Q4	$2.11M	Buy	+11,872	New	+$2.18M	0.72%	35

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Stenger Family Office's ABBV Position: Q2 2026 in Review

Stenger Family Office increased its AbbVie (ABBV) stake by 6.4% in Q2 2026, buying an estimated $431K and bringing the position to 33,496 shares worth $8.43M. The position accounts for 1.34% of the portfolio, ranked #20.

Stenger Family Office first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 1,514 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Stenger Family Office held 33,496 shares of AbbVie worth $8.43M as of Q2 2026.
Stenger Family Office bought 2,005 AbbVie shares in Q2 2026, an estimated $431K.
AbbVie made up 1.34% of Stenger Family Office's portfolio in Q2 2026, its #20 holding.
Stenger Family Office first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
1,514 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stenger Family Office's 13F filing for Q2 2026, filed 13 Jul 2026.